Remgro

Remgro EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Remgro (REM.JO) as of Sep 27, 2026 is 4.47 B ZAR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 3.81 B ZAR — a change of 17.38% (higher).

EBITDA

4.47 BZAR

YoY

17.38%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Remgro is 2026 4.47 B ZAR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Remgro was 2025 3.81 B ZAR. It decreases by 17.38% higher compared to the previous year.

The Remgro EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
2.07 B ZAR
Jan 1, 2019
4.58 B ZAR
Jan 1, 2020
3.23 B ZAR
Jan 1, 2021
6.16 B ZAR
Jan 1, 2022
6.95 B ZAR
Jan 1, 2023
3.37 B ZAR
Jan 1, 2024
3.81 B ZAR
Jan 1, 2025
4.47 B ZAR
The Remgro EBITDA history
YEAREBITDAYoY
4.47 BZAR+17.38%
3.81 BZAR+13.13%
3.37 BZAR-51.57%
6.95 BZAR+12.86%
6.16 BZAR+90.89%
3.23 BZAR-29.56%
4.58 BZAR+121.30%
2.07 BZAR+36.90%
1.51 BZAR+22.03%
1.24 BZAR-42.88%
2.17 BZAR+71.87%
1.26 BZAR—
Access this data via the Eulerpool API
Get Free API Key

Remgro Stock analysis

What does Remgro do? Remgro Ltd is a diversified company that offers a wide range of products and services in various business sectors. The company was founded in 1990 and is based in Stellenbosch, South Africa. The company emerged from the acquisition of Rembrandt Group Ltd, which was founded by South African billionaire and philanthropist Anton Rupert. Remgro has been a diversified company since its inception, operating in various business sectors. The company is divided into three main areas: finance, healthcare, and infrastructure. Some of the key holdings of Remgro in the finance sector include FirstRand Limited, RMB Holdings Limited, and Momentum Metropolitan Holdings Limited. In the healthcare sector, Remgro is active through its subsidiaries Mediclinic International plc and Erste Holdings Limited. Mediclinic operates clinics and hospitals in South Africa, the UK, and the UAE, offering a wide range of medical services. Erste Holdings is one of the largest pharmaceutical companies in South Africa, producing a wide range of medications and healthcare products. In the infrastructure sector, Remgro is involved through its stake in South African utility company PowerX, which is a leading provider of electricity and water in the country. Overall, Remgro is a diversified company operating in various sectors and offering a wide range of products and services. Remgro is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Remgro stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Remgro is 4.47 B ZAR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Remgro changed from 3.81 B ZAR to 4.47 B ZAR, representing a 17.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Remgro since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s ZAR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Remgro historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Remgro

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Remgro